VYNE THERAPEUTICS INC (VYNE) Stock Income Statement
NASDAQ:VYNE • US92941V3087
Current stock price
0.6451 USD
+0 (+0.77%)
At close:
0.6488 USD
+0 (+0.57%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 570.00K | 501.00K | 424.00K | 480.00K | 930.00K | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | 3.35M | |||
| Gross Profit | N/A | N/A | N/A | N/A | 11.41M | |||
| Operating Expenses | 30.32M | 44.14M | 29.68M | 34.77M | 39.84M | |||
| Research and Development | 19.24M | 30.95M | 16.31M | 18.39M | 19.54M | |||
| Selling, General, and Administrative Expenses | 11.06M | 13.19M | 13.38M | 16.39M | 20.30M | |||
| Operating Income | -29.75M | -43.64M | -29.26M | -34.30M | -38.91M | |||
| Interest Income/Expense | N/A | N/A | N/A | 0.00 | -5.61M | |||
| Other Income/Expense | 3.02M | 3.83M | 1.39M | 360.00K | -140.00K | |||
| Income Before Taxes | -26.73M | -39.80M | -27.87M | -33.93M | -44.66M | |||
| Income Tax | 4.00K | 4.00K | 0.00 | 10.00K | -450.00K | |||
| Net Income | -26.48M | -39.83M | -28.45M | -23.21M | -73.33M | |||
| EBITDA | -29.73M | -43.63M | N/A | -34.23M | -38.80M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.63 | -0.93 | -2.76 | -7.27 | -25.63 | |||
| Non GAAP EPS | -0.61 | -0.94 | -7.04 | -11.07 | -23.04 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | 1226.56% | |||
| Profit Margin | -4646.14% | -7950.90% | -6710.38% | -4835.42% | -7884.95% | |||
| Operating Profit Margin | -5219.12% | -8709.98% | -6900.47% | -7145.83% | -4183.87% | |||
All data in USD